Focusing on key scientific questions about the development mechanism of major diseases and correspondingly translational applications, Shenzhen innovation institute of synthetic biology medical center use of synthetic biology technologies to develop innovative diagnosis, treatment methods and individualized treatment applications. The center has deployed three major research fields, which are basic medical research, synthetic enabling technology and translational medicine, and conducted extensive explorations in clinical applications as well. In order to take advantages of combining synthetic biology with medical research, the center has gathered multidisciplinary and complementary groups from synthetic biology, disease genomics, tumor biology, bioinformation, proteomics, metabolomics and so on, with more than 20 outstanding young Principal Investigators and over 200 researchers.
The main research directions are prostate urogenital system tumors, the pathogenesis of male infertility and translational medical research.
The main research directions are tumor synthetic biology, bladder cancer mechanism and tumor immune cell reprogramming.